Overview

Secondary Prevention of Osteoporosis

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to develop and implement an evidence based protocol for the secondary prevention of osteoporotic fractures and falls, and to determine how compliance with this intervention improves muscle strength and functional status following a fracture.
Phase:
Phase 3
Details
Lead Sponsor:
Hebrew Rehabilitation Center, Boston
Hebrew SeniorLife
Collaborators:
GlaxoSmithKline
Merck Sharp & Dohme Corp.
National Institute on Aging (NIA)
Treatments:
Alendronate
Calcium
Calcium Carbonate
Calcium, Dietary
Cholecalciferol